Bionano genomics to present at the 2022 btig medtech, digital health, life science & diagnostic tools conference

San diego, feb. 09, 2022 (globe newswire) -- bionano genomics, inc. (bngo), pioneer of optical genome mapping (ogm) solutions on the saphyr® system and provider of nxclinical™, the leading software solution for visualization, interpretation and reporting of genomic data, announced today that company management will present virtually at the btig medtech, digital health, life science & diagnostic tools conference. erik holmlin, phd, bionano's president and chief executive officer, is scheduled to participate in a fireside chat on wednesday, february 16th, 2022 at 2:30 pm et. btig hosted events are intended for prospective and existing btig clients. to listen to the live event, please contact your btig representative with interest.
BNGO Ratings Summary
BNGO Quant Ranking